Fig. 3From: Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancerThe prognostic value of SHMT2 mRNA in kidney cancer patients (K-M plotter) and the IHC of SHMT2 in kidney cancer (HPA). a, b Survival curve of SHMT2 for renal papillary cell carcinoma and renal clear cell carcinoma, respectively. c, d: IHC of SHMT2 in kidney cancer from healthy and pathological tissuesBack to article page